Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial - The Lancet Diabetes & Endocrinology
Por um escritor misterioso
Descrição
Current and Emerging Treatment Strategies for Graves' Orbitopathy
Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and
Effect of dapagliflozin on the rate of decline in kidney function
Effect of dapagliflozin on the rate of decline in kidney function
Statin use associated with lower incidence of developing thyroid
Full article: How can we prevent disease relapse in Graves
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and
PDF) Application and impact assessment of an interactive journal
Current concepts regarding Graves' orbitopathy - Bartalena - 2022
de
por adulto (o preço varia de acordo com o tamanho do grupo)
